DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$4,236,000
-51.1%
68,000
-44.3%
0.19%
-42.8%
Q1 2017$8,671,000
-75.7%
122,000
-89.0%
0.33%
-78.0%
Q1 2016$35,704,000
+2.3%
1,113,654
+86.0%
1.52%
+7.4%
Q4 2015$34,913,000
+27.1%
598,854
-7.7%
1.42%
+33.1%
Q3 2015$27,468,000
+23.4%
649,064
+112.8%
1.06%
+43.3%
Q2 2015$22,265,000
-25.6%
305,000
-48.8%
0.74%
-23.4%
Q1 2015$29,909,000
+211.2%
595,443
+126.7%
0.97%
+180.9%
Q4 2014$9,612,000
-32.3%
262,625
-41.7%
0.34%
-33.3%
Q3 2014$14,196,000450,6670.52%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders